Holen Sie sich die Stockscreener-App
36.65
14.60%
4.67
Schlusskurs vom Vortag:
$31.98
Offen:
$32
24-Stunden-Volumen:
142.23K
Relative Volume:
2.19
Marktkapitalisierung:
$40.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-53.86M
KGV:
-0.6728
EPS:
-54.4704
Netto-Cashflow:
$-28.76M
1W Leistung:
+98.83%
1M Leistung:
+98.83%
6M Leistung:
+515.97%
1J Leistung:
+197.48%
1-Tages-Spanne:
$32.00
$40.02
1-Wochen-Bereich:
$18.25
$42.12
52-Wochen-Spanne:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Vergleichen Sie APLM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
36.65 | 68.54M | 0 | -53.86M | -28.76M | -54.47 |
|
LION
Lionsgate Studios Corp
|
5.91 | 1.74B | 3.13B | -174.20M | -111.20M | -0.6937 |
|
CCCX
Churchill Capital Corp X
|
21.10 | 1.03B | 0 | 0 | 0 | 0.00 |
|
HOND
Hcm Ii Acquisition Corp
|
25.92 | 668.73M | 0 | 0 | 0 | 0.00 |
|
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.02 | 590.82M | 0 | 0 | 0 | 0.00 |
|
AEXA
American Exceptionalism Acquisition Corp A
|
11.30 | 565.34M | 0 | 0 | 0 | 0.00 |
Apollomics Inc Aktie (APLM) Neueste Nachrichten
Apollomics Inc trading resumes - MSN
Will earnings trigger a reversal in Apollomics Inc.2025 Market Sentiment & Daily Stock Trend Reports - newser.com
Reversal indicators forming on Apollomics Inc. stockWeekly Trade Analysis & Capital Efficiency Focused Ideas - newser.com
Why Apollomics Inc. Equity Warrant stock is recommended by analystsJuly 2025 Volume & Technical Pattern Based Signals - Trung tâm Dự báo KTTV quốc gia
Why Apollomics Inc. Equity Warrant stock is rated strong buyEarnings Growth Summary & Risk Adjusted Swing Trade Ideas - Trung tâm Dự báo KTTV quốc gia
Aug Mood: Will Apollomics Inc. Equity Warrant stock outperform Dow Jones index2025 Geopolitical Influence & Reliable Price Action Trade Plans - Trung tâm Dự báo KTTV quốc gia
Will Apollomics Inc. Equity Warrant stock recover after recent dropEntry Point & Stepwise Trade Signal Implementation - newser.com
Biotech Shares Jump On Breakthroughs In Tremor And Pain Treatments - Finimize
APLM confirms Nasdaq compliance and switches auditor to Marcum Asia - Stock Titan
Why Apollomics Stock Nosedived 16% After-Hours Today - Asianet Newsable
Apollomics Receives Compliance Notification From Nasdaq - MarketScreener
Apollomics announces continued listing on Nasdaq following hearing cancellation - MarketScreener
Apollomics Inc. Secures Continued Listing on Nasdaq Following Compliance Notification - Quiver Quantitative
Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation - GlobeNewswire
Nasdaq Cancels Hearing; Apollomics to Remain Listed After Staff Finds Compliance on Oct. 14, 2025 - Stock Titan
Is Apollomics Inc. stock attractive for hedge funds2025 Trading Volume Trends & Daily Growth Stock Investment Tips - newser.com
Full technical analysis of Apollomics Inc. Equity Warrant stockPortfolio Update Summary & Risk Managed Trade Strategies - newser.com
Is Apollomics Inc. stock poised for growthSell Signal & Safe Entry Momentum Tips - newser.com
Nasdaq to resume trading of Apollomics shares after month-long halt - Investing.com Nigeria
Nasdaq to resume trading of Apollomics shares after month-long halt By Investing.com - Investing.com South Africa
Nasdaq Resumes Trading in Apollomics Inc. - The Manila Times
Nasdaq Announces Resumption of Trading for Apollomics Inc. Class A Shares and Warrants on October 15, 2025 - Quiver Quantitative
NASDAQ resumes trading in Apollomics shares and warrants - StreetInsider
Trading Resumes Oct. 15 for Apollomics Shares and Warrants; Trading Halted Sept. 17 - Stock Titan
Apollomics sustains APL-101 Phase 2 after $4.1M PIPE and new leadership - Stock Titan
GlobeNewswire by Notified - The Manila Times
Apollomics IncWith Additional Funding and New Leadership, Company Has Reversed Its Wind-up Plans - 富途牛牛
[6-K] – Apollomics Inc. (APLM, APLMW) (CIK 0001944885) | APLM SEC FilingForm 6-K - Stock Titan
Custom watchlist performance reports with Apollomics Inc.July 2025 Decliners & Fast Entry Momentum Alerts - newser.com
Apollomics Inc. Provides Operational Update and Reaffirms Commitment to APL-101 Development Following Leadership Changes and New Funding - Quiver Quantitative
Apollomics says company has reversed its wind-up plans - MarketScreener
$4.1M PIPE funds Apollomics' reversal of wind‑up to continue global Phase 2 APL‑101 (280+ patients) - Stock Titan
Apollomics, Inc. Company Operational Continuity Update - GlobeNewswire
Will Apollomics Inc. Equity Warrant stock reach Wall Street targets2025 Analyst Calls & AI Driven Stock Reports - newser.com
Will breakout in Apollomics Inc. Equity Warrant lead to full recovery2025 Momentum Check & Free Community Consensus Stock Picks - newser.com
Should you hold or exit Apollomics Inc. Equity Warrant nowJobs Report & Free Accurate Trade Setup Notifications - newser.com
Intraday pattern recognizer results for Apollomics Inc.July 2025 WrapUp & Expert Curated Trade Setup Alerts - newser.com
Is Apollomics Inc. Equity Warrant reversing from oversold territorySwing Trade & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-10-10 10:02:49 - newser.com
What machine learning models say about Apollomics Inc.2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - newser.com
Has Apollomics Inc. Equity Warrant formed a bullish divergenceJobs Report & Daily Entry Point Alerts - newser.com
Published on: 2025-10-10 05:12:33 - newser.com
Published on: 2025-10-10 04:27:39 - newser.com
Detecting price anomalies in Apollomics Inc. with AIQuarterly Market Summary & High Return Stock Watch Alerts - newser.com
Apollomics, Inc. (NASDAQ:APLMW) Sees Large Increase in Short Interest - Defense World
Finanzdaten der Apollomics Inc-Aktie (APLM)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.22%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):